McGill, MUHC and Douglas researchers get top marks from Quebec Science magazine

January 09, 2009

Scientists from McGill University, the McGill University Health Centre (MUHC) and the Douglas Mental Health University Institute earn top marks in Québec Science's Top Ten Discoveries of 2008 for their groundbreaking work.

Published in the magazine's February issue, the prestigious annual ranking honours projects by: Alain Brunet, The Douglas/McGill Faculty of Medicine, Psychiatry; McGill Earth and Planetary Sciences professor Don Francis and Ph.D. candidate Jonathan O'Neil; leading cancer researchers Morag Park and Janusz Rak of McGill and the MUHC.

Jonathan O'Neil and Don Francis - Shedding light on Earth's beginnings

McGill Earth and Planetary Sciences researchers Jonathan O'Neil, Ph.D. candidate, and professor Don Francis, were singled out for their discovery of Earth's oldest rocks, found in the Nuvvuagittuq greenstone belt located in Northern Quebec. The researchers used an isotopic tracer to obtain an age of 4.28 billion years for an unusual amphibolite comprised in the belt, making it 250 million years more ancient than any previously discovered terrestrial rocks. The findings offer scientists clues to the earliest stages of our planet's evolution. The rocks are significant not only for their great age but for their chemical composition which gives an unprecedented glimpse of the processes that formed Earth's early crust. "I'm really interested in how the Earth was created, and with these rocks, present very shortly after the Earth's birth, we can begin to understand how the first crust formed on our planet."

To interview Jonathan O'Neil/Prof. Don Francis: contact Cynthia Lee at 514-398-6754

Alain Brunet - Wiping away the trauma of bad memories

A clinical psychologist and associate professor of psychiatry at McGill, Alain Brunet, PhD, has been investigating the impact of psychological trauma on individuals for over 15 years, focusing on the risk factors and developing effective treatments for Post Traumatic Stress Disorder (PTSD). He has discovered a new use for an old medication -propranolol- the first drug that has the potential to cure PTSD. The treatment involves thinking about one's trauma under the influence of the drug. Propranolol works by partly blocking the emotional component of the trauma memory from being saved again into long term memory storage while leaving the other components of the memory intact. With this new discovery, Brunet reports patients being cured of PTSD after only six treatments.

To interview Dr. Brunet: contact Marie-France Coutu at (514) 761-6131, #2769

Morag Park - Uncovering the mysteries of cancerous cells

Dr. Morag Park, scientific director of the Canadian Institutes of Health Research's institute of cancer research focuses her work on the environment surrounding tumours in the breasts. "We know that this environment is pivotal for cancer initiation and progression; different patients have distinct tumour microenvironments at a gene level," explains Dr. Park. "Our findings show that the gene profile of these distinct microenvironments can be used to determine clinical outcome - who will fare well and who will not." Her team has identified a panel of 26 specific genes that could be used to accurately predict clinical outcome. The next step is to produce a reliable functional test that could be performed on patients. They expect it to be ready for clinical trials at the end of 2009.

Janusz Rak - Learning the language of tumours

Dr. Janusz Rak has discovered a new fundamental mechanism of how tumour cells communicate: by releasing bubble-like structures, called oncosomes, that contain cancer-causing proteins. When the oncosomes merge into a healthy recipient cell, they can trigger specific mechanisms to make it act in a malignant and aberrant way. "With this information we can imagine that many mutant proteins are not necessarily confined to the cells that make them, but rather can migrate and spread around," explained Dr. Rak. "This goes against the traditional view that a single 'mutated' cell will simply multiply uncontrollably to the point of forming a tumour. This discovery opens exciting new research avenues, but we also hope that it will lead to positive outcomes for patients."

To interview Drs. Rak or Park: contact Cynthia Lee at 514-398-6754
-end-
About McGill University

McGill University, founded in Montreal, Que., in 1821, is Canada's leading post-secondary institution. It has two campuses, 11 faculties, 10 professional schools, 300 programs of study and more than 33,000 students. McGill attracts students from more than 160 countries around the world. Almost half of McGill students claim a first language other than English - including 6,000 francophones - with more than 6,200 international students making up almost 20 per cent of the student body.

About the Research Institute of the MUHC

The Research Institute of the McGill University Health Centre (RI MUHC) is a world-renowned biomedical and health-care hospital research centre. Located in Montreal, Quebec, the institute is the research arm of the MUHC, the university health center affiliated with the Faculty of Medicine at McGill University. The institute supports over 600 researchers, nearly 1200 graduate and post-doctoral students and operates more than 300 laboratories devoted to a broad spectrum of fundamental and clinical research. The Research Institute operates at the forefront of knowledge, innovation and technology and is inextricably linked to the clinical programs of the MUHC, ensuring that patients benefit directly from the latest research-based knowledge.

The Research Institute of the MUHC is supported in part by the Fonds de la recherche en santé du Québec. For further details visit: www.muhc.ca/research.

About the Douglas

The Douglas is a world-class institute, affiliated with McGill University and World Health Organization, which treats people suffering from mental illness, and offers them hope and cures. Its teams of specialists and researchers continually advance scientific knowledge, integrate it into patient care, and share it with the community to increase awareness and thus eliminating stigma around mental illness. www.douglas.qc.ca

Contact:

Cynthia Lee
Media Relations Officer
McGill University
(514) 398-6754
cynthia.lee@mcgill.ca

Isabelle Kling
Communications Coordinator (research)
MUHC Public Relations and Communications
(514) 843-1560
isabelle.kling@muhc.mcgill.ca

Marie France Coutu
Conseillère en communication
Service des communications et affaires
(514) 761-6131, #2769
marie-france.coutu@douglas.mcgill.ca

McGill University

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.